Doxorubicin-induced cardiovascular toxicity: a longitudinal evaluation of functional and molecular markers.
Bosman M, Krüger D, Van Assche C, Boen H, Neutel C, Favere K, Franssen C, Martinet W, Roth L, De Meyer GRY, Cillero-Pastor B, Delrue L, Heggermont W, Van Craenenbroeck EM, Guns PJ.
Bosman M, et al. Among authors: guns pj.
Cardiovasc Res. 2023 Nov 25;119(15):2579-2590. doi: 10.1093/cvr/cvad136.
Cardiovasc Res. 2023.
PMID: 37625456
Free PMC article.